Reversible blindness in cryptococcal meningitis with human immunodeficiency virus infection
DOI:
https://doi.org/10.18203/2320-6012.ijrms20240553Keywords:
Crypyptococcal meningitis, Anti-retroviral drugs, Immune reconstitution inflammatory syndrome, SteroidsAbstract
Ocular complications in cryptococcal meningitis (CM) are commonly attributed to elevated intracranial pressure (ICP). We report a case of reversible vision loss complicating acquired immunodeficiency syndrome (AIDS) related to CM with a normal ICP. The patient had sudden onset painless blindness during the anti-retroviral therapy (ART) and anti-fungal therapy. On evaluation, clinical and radiological findings of optic neuritis were present. While reviewing the literature for causes of blindness in CM, we concluded the cause was optic neuritis due to immune reconstitution inflammatory syndrome (IRIS) because of concomitant ART intake by the patient. We witnessed dramatic visual improvement after the use of systemic corticosteroids. The potential significance of this case report is to highlight the possible role of corticosteroids in the prevention of blindness due to CM.
Metrics
References
Duggan J, Walls HM. Ocular complications of cryptococcal meningitis in patients with HIV: report of two cases and review of the literature. J Int Assoc Phys AIDS Care. 2012;11(5):283-8.
Aderman CM, Gorovoy IR, Chao DL, Bloomer MM, Obeid A, Stewart JM. Cryptococcal choroiditis in advanced AIDS with clinicopathologic correlation. Am J Ophthalmol Case Rep. 2018;10:51-4.
Kuriakose C, Mishra A, Vanjare H, Raju A, Abraham O. Visual disturbance in patients with cryptococcal meningitis: the road ahead. J Neurosci Rural Pract. 2017;8(1):151.
Vieira MA, Cavalcanti DL, Costa KD, Eulálio OC, Vale CP, Vieira CH, et al. Visual evoked potentials show strong positive association with intracranial pressure in patients with cryptococcal meningitis. Arquivos de Neuropsiquiatria. 2015;73(4):309-13.
More A, Garg R, Malhotra H, Kumar N, Uniyal R. Acute vision loss in postpartum period as presenting symptom of HIV-associated cryptococcal meningitis–an unusual case report. BMC Infect Dis. 2016;16(1):582.
Beardsley J, Wolbers M, Kibengo FM, Ggayi AB, Kamali A, Cuc NT, et al. Adjunctive dexamethasone in HIV-associated cryptococcal meningitis. N Engl J Med. 2016;374(6):542-54.
Boulware DR, Meya D, Muzoora C. ART initiation within the first 2 weeks of cryptococcal meningitis is associated with higher mortality:A multisite randomized trial [abstract 144]. In: Conference on retrovirusesand opportunistic infections (CROI), Atlanta, USA. 2013.
Ofner S, Baker RS. Visual loss in cryptococcal meningitis. J Clin Neuroophthalmol. 1987;7(1):45-8.
Rex JH, Larsen RA, Dismukes WE, Cloud GA, Bennett JE. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine (Baltimore). 1993;72(4):207-24.
Torres OH, Negredo E, Ris J, Domingo P, Catafau AM. Visual loss due to cryptococcal meningitis in AIDS patients. AIDS. 1999;13(4):530-2.
Corti M, Solari R, Cangelosi D, Domínguez C, Yampolsky C, Negroni R, et al. Sudden blindness due to bilateral optic neuropathy associated with cryptococcal meningitis in an AIDS patient. Rev Iberoam Micol. 2010;27(4):207-9.
De Socio GV, Bernini L, Menduno P, Pitzurra L, Leone F, Baldelli F. Monolateral visual loss due to cryptococcal meningitis. J Int Assoc Physicians AIDS Care (Chic). 2011;10(2):76-8.
Ghatalia PA, Vick A, Vattoth S, Roberson GH, Pappas PG. Reversible Blindness in Cryptococcal Meningitis With Normal Intracranial Pressure: Case Report and Review of the Literature. Clin Infect Dis. 2014;59(2):310-3.
Chen CH, Wang SH, Chen WL, Wang WF, Chen SN. Ocular complications caused by Cryptococcus gattii AFLP4/VGI meningitis in an immunocompetent host. Rev Inst Med Trop Sao Paulo. 2016;58:85.
McCabe GA, McHugh JW, Goodwin T, Johnson DF, Fok A, Campbell TG. Ophthalmic manifestations of Cryptococcus gattii species complex: a case series and review of the literature. Int J Ophthalmol. 2022;15(1):119-27.
Downloads
Published
How to Cite
Issue
Section
